COGNICURRENT

Ozempic will soon be available as a generic drug in many populous countries, significantly lowering its price and improving accessibility.

Rio de Janeiro becomes the first city in Brazil to offer the medication Ozempic through its public health system, marking a significant step in the fight against obesity.

This segment covers various news items relevant to Brazil, including the decline in oil prices, an accident involving trucks and motorcycles after a bridge collapse, a car theft involving a baby, developments in a political case, patent issues related to Ozempic, and tax declaration updates.

The article discusses various topics including the execution of a wrestler in Iran, issues with diabetes medication costs in Brazil, a recent transfer indicating cooperation in a corruption case, tax return preparation in Brazil, and highlights from the Lollapalooza festival.

This article covers major news stories including the execution of a wrestling athlete in Iran due to police deaths during protests, Brazil's stance on Ozempic, a prominent artist's rise in the music festival scene, tax declaration advancements, and weather forecasts for the autumn season.

The news highlights various events and developments in Brazil, including the execution of an athlete in Iran and local cultural happenings.

The article covers various news segments including the execution of a wrestler in Iran linked to protests, issues with Ozempic patent in Brazil, delays in SUS dialysis funding, car theft in São Paulo, and the upcoming music festival Lollapalooza.

Vorcaro's transfer to the Federal Police marks a potential opening for plea bargaining, while other updates highlight developments in Brazil's income tax program, Ozempic patent situation, weather expectations for autumn, and the kick-off of Lollapalooza 2026.

The patent for semaglutide, used in medications like Ozempic, expires soon, but Brazil has yet to see affordable national alternatives, with new versions anticipated by June after regulatory approvals.

The patent for semaglutide, the active ingredient in Ozempic and Wegovy, expires, allowing other companies to manufacture and sell similar medications in Brazil.

A new study suggests that GLP-1 agonists, commonly used for diabetes and obesity, may also help reduce the risk of anxiety and depression.

The impending patent expiration of the weight-loss drug Ozempic is expected to lead to a significant increase in its availability and use, impacting various sectors like food and restaurants in Brazil.

India is set to see the expiration of a patent for the diabetes drug Ozempic, paving the way for cheaper alternatives to enter the market.

A new study indicates that weight loss injections like Ozempic and Wegovy may help decrease symptoms of anxiety and depression and lower the risk of drug abuse.

Recent studies of medications like Ozempic reveal significant weight loss may come from lean mass rather than fat, raising concerns about muscle loss.

The expiration of the semaglutide patent in India could lead to more affordable weight loss drugs, making them accessible to a larger population.

A new study indicates that the drugs Ozempic and Wegovy may alleviate symptoms of anxiety and depression by reducing the risk of worsening mental health.

A new study shows that patients may not experience significant weight regain after stopping GLP-1 medications like Ozempic, contrary to earlier beliefs.

India is expected to reduce obesity rates significantly with the impending expiration of the semaglutide patent, allowing for cheaper generic versions of popular weight-loss drugs.

India is poised to significantly lower obesity rates with the upcoming expiration of the semaglutide patent, allowing local pharmaceutical companies to produce cheaper generic versions of Ozempic and Wegovy.

Amy Schumer revealed her adverse reactions to the weight-loss drug Ozempic, which led her to discontinue its use despite initial weight loss.

The expiration of the Ozempic patent in populous countries like India and China paves the way for cheaper generic versions of GLP-1 medications, significantly impacting global health.

Celebrity agent Dermot McNamara discusses the stigma around celebrities using weight loss medications like Ozempic and Wegovy, highlighting the reluctance to admit such practices.

The patent on semaglutide, the active ingredient in Ozempic, expires in Brazil, possibly leading to lower prices and generic versions of the drug in the future.

The report covers various news items including oil movements in the Strait of Hormuz, a deputy in Ceará under investigation, new internet rules for children, the Central Bank's actions regarding a conglomerate, suspension of loans by INSS, potential price changes on Ozempic, and weather conditions as autumn begins.

The use of the obesity drug Ozempic is growing in Finland, but experts warn that weight may return quickly without long-term lifestyle changes.

Mika, a 35-year-old man, quickly obtained a prescription for the weight-loss drug Ozempic through a brief online consultation, raising concerns about the telehealth practices involved in prescribing such medication.

The recent Oscar gala highlighted Hollywood's ignorance of global crises, as celebrities made jokes while serious issues like war were present.

A Finnish man named Mika secured a prescription for the weight loss drug Ozempic in just five minutes through a chat consultation with his doctor.

A 67-year-old fitness coach, Bobbi Parker-Hall, claims that the medication Ozempic has helped her maintain a youthful appearance and improved her sex life.

Martha Stewart shares her cardiologist's recommendation of beetroot powder as a beneficial addition to her smoothie, likening its effects to that of Ozempic.

A study from the University of Cambridge reveals that one year after stopping weight loss medications like Ozempic, individuals tend to regain about 60% of their lost weight, with a stabilization of rebound effects thereafter.

A young American content creator criticized the widespread use of the weight loss drug Ozempic among those who don't actually need it in a viral TikTok video.

The article discusses how frozen bread can help regulate blood sugar and promote gut health, offering a surprising new approach to traditional carb consumption.

People using weight-loss drugs like Ozempic are spending more on premium chocolates, contrary to expectations that such medications would decrease interest in sweets.

Brazilian President Lula da Silva emphasizes the importance of physical activity and healthy eating while discussing the use of Ozempic for weight loss.

Comedian Migue Granados addressed rumors of using Ozempic for weight loss, firmly denying any use of the drug during an Instagram Q&A.

The FDA issued a formal warning to Novo Nordisk for serious failures in reporting adverse effects associated with its drugs Ozempic and Wegovy.

The FDA has issued a warning letter to Novo Nordisk for failing to adequately report serious and unexpected adverse effects linked to Ozempic and Wegovy medications.

Novo Nordisk has received a warning letter from the FDA regarding its reporting procedures for possible side effects linked to its medications following three deaths in the U.S.

A study reveals that patients using Wegovy face a nearly fivefold increased risk of sudden sight loss compared to those using Ozempic.

Novo Nordisk received a warning letter from the FDA for not reporting all suspected side effects associated with its drug Ozempic, which include two deaths and a suicide incident.

The FDA has criticized Novo Nordisk for its inadequate reporting procedures regarding side effects of the diabetes medication Ozempic and the weight-loss drug Wegovy.

Brazilian pharmaceutical EMS aims to introduce its generic version of Ozempic to the market by September, contingent on the approval from health agency Anvisa within the next 60 days.

Medical associations in Latvia stress the importance of not allowing isolated cases of improper prescribing of 'Ozempic' to hinder its use in diabetes treatment.

The expiration of the semaglutide patent in Brazil will not lead to immediate price reductions for Ozempic due to regulatory and logistical challenges.

Lindt claims that users of weight loss drugs are purchasing more chocolate than the general population, defying previous expectations.

The expiration of the semaglutide patent in Brazil is unlikely to lead to immediate price reductions for Ozempic due to regulatory and manufacturing challenges.

Recent research indicates that chia seeds can activate genes related to satiety, potentially impacting weight management.

Danish pharmaceutical giant Novo Nordisk has reached an agreement with the US online pharmacy Hims & Hers, dropping its lawsuit against the company regarding the sale of a copy of Wegovy.